Cargando…
A randomized, controlled trial of Veriset™ hemostatic patch in halting cardiovascular bleeding
BACKGROUND: Obtaining hemostasis during cardiovascular procedures can be a challenge, particularly around areas with a complex geometry or that are difficult to access. While several topical hemostats are currently on the market, most have caveats that limit their use in certain clinical scenarios s...
Autores principales: | Glineur, David, Hendrikx, Marc, Krievins, Dainis, Stradins, Peteris, Voss, Bernhard, Waldow, Thomas, Haenen, Luc, Oberhoffer, Martin, Ritchie, Caroline M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846302/ https://www.ncbi.nlm.nih.gov/pubmed/29563844 http://dx.doi.org/10.2147/MDER.S145651 |
Ejemplares similares
-
Safety and effectiveness of a synthetic hemostatic patch for intraoperative soft tissue bleeding
por: Schuhmacher, Christoph, et al.
Publicado: (2015) -
Does the additional usage of a local hemostatic patch reduce bleeding after aortic reimplantation?
por: Ostrowski, Stanisław, et al.
Publicado: (2018) -
Rare diseases and orphan drugs: Latvian story
por: Logviss, Konstantins, et al.
Publicado: (2014) -
Impact of orphan drugs on Latvian budget
por: Logviss, Konstantins, et al.
Publicado: (2016) -
Characteristics of clinical trials in rare vs. common diseases: A register-based Latvian study
por: Logviss, Konstantins, et al.
Publicado: (2018)